BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26499176)

  • 21. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.
    Kinsley B
    Clin Ther; 2007; 29 Suppl D():S153-60. PubMed ID: 18191067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence.
    Kaiserman K; Jung H; Benabbad I; Karges B; Polak M; Rosilio M
    Pediatr Diabetes; 2017 Mar; 18(2):81-94. PubMed ID: 27390032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating the mother--protecting the unborn: the safety of hypoglycemic drugs in pregnancy.
    Klieger C; Pollex E; Koren G
    J Matern Fetal Neonatal Med; 2008 Mar; 21(3):191-6. PubMed ID: 18297574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinatal outcomes in pregnancies managed with antenatal insulin glargine.
    Egerman RS; Ramsey RD; Kao LW; Bringman JJ; Haerian H; Kao JL; Bush AJ
    Am J Perinatol; 2009 Sep; 26(8):591-5. PubMed ID: 19370512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of declining insulin requirements during pregnancy in patients with pre-gestational gestational diabetes mellitus.
    Ram M; Feinmesser L; Shinar S; Maslovitz S
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():148-152. PubMed ID: 28628847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of insulin analogs during pregnancy: a meta-analysis.
    Lv S; Wang J; Xu Y
    Arch Gynecol Obstet; 2015 Oct; 292(4):749-56. PubMed ID: 25855052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pharmacodynamic intrasubject variability of insulin lispro protamine suspension and insulin glargine in subjects with type 1 diabetes.
    Ocheltree SM; Hompesch M; Wondmagegnehu ET; Morrow L; Win K; Jacober SJ
    Eur J Endocrinol; 2010 Aug; 163(2):217-23. PubMed ID: 20508081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus.
    King AB; Clark D; Wolfe GS
    Endocr Pract; 2012; 18(3):382-6. PubMed ID: 22440988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and tolerability of once or twice daily neutral protamine hagedorn insulin in fasting pregnant women with diabetes during Ramadan.
    Nor Azlin MI; Adam R; Sufian SS; Wahab NA; Mustafa N; Kamaruddin NA; Jamil MA
    J Obstet Gynaecol Res; 2011 Feb; 37(2):132-7. PubMed ID: 21159037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic and immunologic effects of insulin lispro in gestational diabetes.
    Jovanovic L; Ilic S; Pettitt DJ; Hugo K; Gutierrez M; Bowsher RR; Bastyr EJ
    Diabetes Care; 1999 Sep; 22(9):1422-7. PubMed ID: 10480503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin lispro and regular insulin in pregnancy.
    Bhattacharyya A; Brown S; Hughes S; Vice PA
    QJM; 2001 May; 94(5):255-60. PubMed ID: 11353099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a role for oral antihyperglycemics in gestational diabetes and type 2 diabetes during pregnancy?
    Homko CJ; Sivan E; Reece AE
    Treat Endocrinol; 2004; 3(3):133-9. PubMed ID: 16026109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro.
    Loukovaara S; Immonen I; Teramo KA; Kaaja R
    Diabetes Care; 2003 Apr; 26(4):1193-8. PubMed ID: 12663596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin analogues and management of diabetes mellitus.
    Vaidyanathan B; Menon PS
    Indian J Pediatr; 2000 Jun; 67(6):435-41. PubMed ID: 10932964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New therapies for the pregnant patient with diabetes.
    El-Sayed YY; Lyell DJ
    Diabetes Technol Ther; 2001; 3(4):635-40. PubMed ID: 11911177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial.
    Ibrahim MI; Hamdy A; Shafik A; Taha S; Anwar M; Faris M
    Arch Gynecol Obstet; 2014 May; 289(5):959-65. PubMed ID: 24217938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes.
    Garg SK; Frias JP; Anil S; Gottlieb PA; MacKenzie T; Jackson WE
    Endocr Pract; 2003; 9(3):187-93. PubMed ID: 12917059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of diabetes in pregnancy.
    Balaji V; Seshiah V
    J Assoc Physicians India; 2011 Apr; 59 Suppl():33-6. PubMed ID: 21823253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is insulin lispro safe in pregnant women: Does it cause any adverse outcomes on infants or mothers?
    Aydin Y; Berker D; Direktör N; Ustün I; Tütüncü YA; Işik S; Delibaşi T; Guler S
    Diabetes Res Clin Pract; 2008 Jun; 80(3):444-8. PubMed ID: 18359121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential for the use of insulin lispro in pregnancy complicated by diabetes.
    Carr KJ; Lindow SW; Masson EA
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):323-9. PubMed ID: 16801307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.